Liu Weizhen et al., Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinsons disease, Neuroscience (September 2015), 42-50, [143]
Behavioral Interventions and Medication Durability Research suggests behavioral interventions enhance GLP-1 efficacy and weight-loss maintenance
It looked at almost 18,000 participants with excess weight or obesity and cardiovascular disease who took weekly Wegovy injections for four years and made lifestyle changes, like following a reduced-calorie diet and doing more exercise
(56:54) Understanding the incentives of a compounding pharmacy
Does the cessation of the shortage exception apply only to injectable GLP-1 medications, or does it include oral versions as well
Hypoglycemia and Blood Sugar Fluctuations IGF-1 LR3 can affect blood sugar levels